IR
63
-5
PH
60
-7
USB
53
2
EXR
39
2
URI
69
3
OMC
58
-6
NRG
52
-3
RL
70
-6
NWL
50
-3
CTSH
51
-4
MRK
48
26
LLY
56
2
VRSK
56
-3
GRMN
43
-3
R
57
-2
VMC
59
-6
GILD
58
2
LB
41
-19
HBAN
59
3
CMCSA
39
2
IR
63
-5
PH
60
-7
USB
53
2
EXR
39
2
URI
69
3
OMC
58
-6
NRG
52
-3
RL
70
-6
NWL
50
-3
CTSH
51
-4
MRK
48
26
LLY
56
2
VRSK
56
-3
GRMN
43
-3
R
57
-2
VMC
59
-6
GILD
58
2
LB
41
-19
HBAN
59
3
CMCSA
39
2
Financhill
Back

Corbus Pharmaceuticals Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
20

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
17.54
Seasonality Move:
5.98%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.37
Seasonality Move:
19.45%
Sell
20
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $17.46. The Score for CRBP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.39. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $17.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.94 Sell
Relative Strength Index (14 RSI): 26.71 Sell
Chaikin Money Flow: -214906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.79 - 33.31) Sell
Bollinger Bands (100): (30.61 - 59.73) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 43.35 Sell
Chaikin Money Flow: -59516 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.43 - 13.29) Sell
Bollinger Bands (100): (11.37 - 14.45) Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.43 Sell
20-day SMA: 19.29 Sell
50-day SMA: 39.3 Sell
200-day SMA: 38.47 Sell
8-day EMA: 18.49 Sell
20-day EMA: 22.7 Sell
50-day EMA: 33.37 Sell
200-day EMA: 35.8 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.69 Sell
20-day SMA: 12.8 Sell
50-day SMA: 13.82 Sell
200-day SMA: 12.31 Buy
8-day EMA: 12.69 Sell
20-day EMA: 12.96 Sell
50-day EMA: 13.27 Sell
200-day EMA: 11.76 Buy

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):